Newsroom
The Latest News From the Ivy Center
The Ivy Brain Tumor Center at Barrow Neurological Institute strives to be a valuable resource for any brain tumor or brain cancer-related media needs. Our media relations team is happy to help answer questions and arrange interviews. The expert neurosurgeons, neuro-oncologists and scientists at the Ivy Center are available to speak on a variety of topics.
Our state-of-the-art media studio is available for audio and video interviews. We can also arrange filming opportunities at various locations around the center and labs.
To contact the media relation team, call Jennifer Keeler at 602-670-4400 or email: [email protected].
Please see below for the latest media coverage and news from the Ivy Center. To read about our inspiring patients and those behind the scenes at the Ivy Center, visit the Ivy Blog.
Phoenix nurse inspires hope during battle with brain cancer
Dr. Nader Sanai, director of the Ivy Brain Tumor Center, says although the survival rate is low it doesn't mean there isn't hope to beat cancer. "These are populational statistics, they don't describe you or predict your future." He and Youngblood are teaming up to bring awareness to the disease for Glioblastoma Awareness Day. Sanai says a day focusing on brain cancer is important because it hasn't seen the same progress in therapies like breast or prostate cancer.
Arizona is Leading the Charge in Battling one of the ‘Deadliest Diseases Known to Mankind’
Chamber Business News highlights the Ivy Brain Tumor Center's resilience in fighting brain tumors despite the pandemic and the importance of Glioblastoma Awareness Day. Observed as a day to honor those who have been impacted by the disease, the initiative also supports efforts to develop better treatment options that will improve patients’ long-term prognosis.
Phoenix nurse who helped fight New York’s COVID-19 surge now battling brain cancer
The Arizona Republic shares the story of Ian Youngblood, a 29-year-old nurse from Arizona who received a harrowing diagnosis of glioblastoma while helping fight COVID-19 on the frontlines in NYC. Dr. Nader Sanai weighs in on why these types of tumors are so hard to control and what it will take to move the needle on identifying new, effective treatment options.
Ivy Brain Tumor Center and COVID Nurse, Ian Youngblood, Honor Second Annual National Glioblastoma Day on July 22, 2020
Dr. Nader Sanai, director of the Ivy Brain Tumor Center and Ian Youngblood, RN, who was recently diagnosed with a brain tumor, have come together for the second annual Glioblastoma Awareness Day (#GBMDay) on July 22, 2020 to raise national consciousness.
Nurse who fought coronavirus in New York now battles his own brain cancer
Ian's story has moved the country for his strength and selfless service on the COVID-19 frontlines in NYC. Now, facing a battle of his own, he's turning to Dr. Nader Sanai and his team at the Ivy Brain Tumor Center and Barrow Neurological Institute to help him fight one of the most aggressive forms of brain cancer, glioblastoma.
Benjamin Cravatt, Ph.D. Joins Ivy Brain Tumor Center’s Scientific Advisory Board
The Ivy Brain Tumor Center at Barrow Neurological Institute has announced the appointment of Benjamin Cravatt, Ph.D to its Scientific Advisory Board. Dr. Cravatt is a world-renowned chemical biologist with extensive experience in drug discovery and drug development.
Meghan McCain recognizes Ivy Brain Tumor Center
On May 27, 2020, Meghan McCain used her national platform to recognize Brain Tumor Awareness Month and her personal connection to this deadly disease on The View. She encourages people to support the Ivy Brain Tumor Center in our mission to cure brain cancer.
Ivy Brain Tumor Center Launches New Clinical Trial For Recurrent Glioblastoma
The Ivy Brain Tumor Center at Barrow Neurological Institute announced that patient recruitment has opened for a Phase 0 clinical trial to evaluate two targeted therapy drugs, abemaciclib and LY3214996. The study will evaluate central nervous system (CNS) penetration in patients with recurrent glioblastoma scheduled for resection. This is the first time a combination of these two drugs will be tested in brain tumor patients.
Ivy Foundation Makes Multi-million Dollar Contribution To AZ Coronavirus Relief Fund
“It’s very important to me that the medical personnel in this state have the right tools and supplies to fight this battle,” said Catherine Ivy, co-founder of the Ivy Brain Tumor Center.
Barrow Neurosurgeon to Study Rewiring of Brain in Diabetes
Barrow Neurological Institute neurosurgeon, Dr. Zaman Mirzadeh has received a three-year, $1.8 million grant from the U.S. Department of Defense (DoD) to study the rewiring of the brain to normalize blood sugar levels in diabetes.
As a member of the Ivy Center team, Dr. Mirzadeh runs a lab focused on identifying unique metabolic pathways co-opted by glioblastoma to drive tumor growth.